3 – 5AM Partners VI, LLC Submits SEC Filing (0001829051) for Reporting Period
In a recent SEC filing, 3 - 5AM Partners VI, LLC (CIK: 0001829051) disclosed important information that investors and stakeholders...
Day: July 18, 2024
Artiva Biotherapeutics, Inc. Submits SEC Filing: Key Details Revealed
In a recent SEC filing, Artiva Biotherapeutics, Inc. (Issuer) disclosed important information that sheds light on the company's current financial...
GC Corp. Submits SEC Filing (Form 3) – Learn More About the Company (0001931382)
GC Corp. (0001931382) recently submitted a significant SEC filing, indicating important developments within the company. The filing could potentially impact...
GC Cell Corp (0001931891) Files SEC Report, Reveals Key Information
GC Cell Corp, a company known for its innovative cellular research, has recently submitted a significant SEC filing. The filing...
Artiva Biotherapeutics, Inc. SEC Filing Signals Major Development in Biotech Industry
Artiva Biotherapeutics, Inc. recently submitted a significant SEC filing, catching the attention of investors and industry experts. The filing provides...
Stoppel Laura (0001865119) Reports Activity: Key Details Revealed
In a recent SEC filing, Stoppel Laura, identified by the unique identifier 0001865119, has reported a significant transaction. The filing...
Elizabeth L. Hougen (0001074773) Reports 3 – Form to SEC
In a recent SEC filing, Elizabeth L. Hougen, a reporting person associated with a certain company, has submitted Form 3....
Artiva Biotherapeutics, Inc. Files Important SEC Form – (0001817241) – Issuer
Artiva Biotherapeutics, Inc. (0001817241) recently submitted a significant SEC filing that has caught the attention of investors and industry experts....
Former WWE Superstar Daniel Bryan Files SEC Form 3 for Reporting Purposes
In a recent SEC filing, professional wrestler Daniel Bryan, also known as Bryan Danielson, reported his holdings as required by...
Artiva Biotherapeutics, Inc. SEC Filing Alert: What You Need to Know
Artiva Biotherapeutics, Inc. recently filed a Form D with the Securities and Exchange Commission, indicating a significant development for the...
Artiva Biotherapeutics, Inc. Files Important SEC Form – Learn More About the Company and Filing
Artiva Biotherapeutics, Inc. recently filed a Form 3 with the Securities and Exchange Commission (SEC), signaling significant changes within the...
Huh Yong-Jun’s SEC Filing (Form 3) Reportedly Submitted for Public Disclosure
In a recent SEC filing, Huh Yong-Jun (0001931083) has been identified as the reporting person. The significance of this filing...